DK4048229T3 - Farmaceutisk sammensætning til anvendelse i behandlingen af cystitis af forskellige ætiologier - Google Patents

Farmaceutisk sammensætning til anvendelse i behandlingen af cystitis af forskellige ætiologier

Info

Publication number
DK4048229T3
DK4048229T3 DK20801016.5T DK20801016T DK4048229T3 DK 4048229 T3 DK4048229 T3 DK 4048229T3 DK 20801016 T DK20801016 T DK 20801016T DK 4048229 T3 DK4048229 T3 DK 4048229T3
Authority
DK
Denmark
Prior art keywords
cystitis
treatment
pharmaceutical composition
various aetiologies
aetiologies
Prior art date
Application number
DK20801016.5T
Other languages
English (en)
Inventor
Carlo Pizzocaro
Anna Maria Zanellato
Mauro Pavan
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Application granted granted Critical
Publication of DK4048229T3 publication Critical patent/DK4048229T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK20801016.5T 2019-10-24 2020-10-22 Farmaceutisk sammensætning til anvendelse i behandlingen af cystitis af forskellige ætiologier DK4048229T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000019762A IT201900019762A1 (it) 2019-10-24 2019-10-24 Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia
PCT/IB2020/059922 WO2021079303A1 (en) 2019-10-24 2020-10-22 Pharmaceutical composition for use in the treatment of cystitis of various etiologies

Publications (1)

Publication Number Publication Date
DK4048229T3 true DK4048229T3 (da) 2026-02-16

Family

ID=69743769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20801016.5T DK4048229T3 (da) 2019-10-24 2020-10-22 Farmaceutisk sammensætning til anvendelse i behandlingen af cystitis af forskellige ætiologier

Country Status (12)

Country Link
US (1) US20240075054A1 (da)
EP (1) EP4048229B1 (da)
CA (1) CA3153498A1 (da)
DK (1) DK4048229T3 (da)
ES (1) ES3062926T3 (da)
FI (1) FI4048229T3 (da)
HR (1) HRP20260259T1 (da)
IT (1) IT201900019762A1 (da)
LT (1) LT4048229T (da)
PL (1) PL4048229T3 (da)
PT (1) PT4048229T (da)
WO (1) WO2021079303A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020252003A1 (en) 2019-06-13 2020-12-17 Hollister Incorporated Reusable urinary catheter products
US12440644B2 (en) 2019-06-25 2025-10-14 Hollister Incorporated Reusable urinary catheter products

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN163192B (da) 1983-10-11 1988-08-20 Fidia Spa
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
IN181358B (da) * 1995-02-14 1998-05-30 Bioniche Inc
IT1296689B1 (it) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario
EP3406244B1 (en) * 2009-04-15 2023-06-07 BMG Pharma S.p.A. Compositions comprising zinc gluconate and taurine for mucosal or dermal disorders
IT1402385B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis
IT1402384B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium
US9849086B2 (en) * 2012-03-19 2017-12-26 Nanologix Research, Inc. Method and composition for treating cystitis
ITMI20131971A1 (it) * 2013-11-26 2015-05-27 Fidia Farmaceutici Composizioni farmaceutiche ad attività idratante e lubrificante
CA2896038C (en) * 2015-07-03 2022-08-09 Glycobiosciences Inc. Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof
IT201600079633A1 (it) 2016-07-28 2018-01-28 Fidia Farm Spa Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico
IT201700081449A1 (it) 2017-07-18 2019-01-18 Fidia Farm Spa Procedimento di purificazione dell'acido ialuronico

Also Published As

Publication number Publication date
IT201900019762A1 (it) 2021-04-24
EP4048229B1 (en) 2025-12-03
US20240075054A1 (en) 2024-03-07
PT4048229T (pt) 2026-02-13
LT4048229T (lt) 2026-03-10
CA3153498A1 (en) 2021-04-29
HRP20260259T1 (hr) 2026-04-10
WO2021079303A1 (en) 2021-04-29
PL4048229T3 (pl) 2026-04-20
EP4048229A1 (en) 2022-08-31
ES3062926T3 (en) 2026-04-14
FI4048229T3 (fi) 2026-02-12

Similar Documents

Publication Publication Date Title
DK3785733T3 (da) Farmaceutisk sammensætning til behandling af autisme
DK4028010T3 (da) Vs-6063 i kombination med ch5126766 til behandlingen af kræft
DK3429571T3 (da) Kombinationer af lsd1-hæmmere til anvendelse til behandling af neoplastiske sygdomme
DK3350157T3 (da) Forbindelser og sammensætninger til intracellulær afgivelse af terapeutiske midler
DK3998261T3 (da) Pyrimidin-2-ylamino-1h-pyrazoler som lrrk2-inhibitorer til brug i behandlingen af neurodegenerative lidelser
DK3328414T3 (da) Sammensætning til anvendelse i fremme af sårheling
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3806898T3 (da) Gremlin-1-antagonist til anvendelse i behandling af cancer
DK3435996T3 (da) Elafibranor til anvendelse i behandlingen af primær biliær cholangitis
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3962601T3 (da) 5-HT2A-agonister til anvendelse til behandling af depression
DK3328864T3 (da) Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser
DK3532029T3 (da) Flydende farmaceutisk sammensætning
DK3768284T3 (da) Sammensætninger af enterococcus flagellin til anvendelse i terapi
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
DK3592355T3 (da) KX2-391/KX-01 til anvendelse i behandling af aktinisk keratose
DK3522904T3 (da) Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux
HRP20260406T1 (hr) Lumateperon za primjenu u liječenju shizofrenije
DK3784210T3 (da) Topisk farmaceutisk sammensætning til behandling af analfissurer og hæmorider
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
DK3506901T3 (da) Anvendelse af kynurensyre til behandling af muskelatrofi
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
DK3908321T3 (da) Farmaceutisk sammensætning
DK3998067T3 (da) Sammensætninger og fremgangsmåder til behandling af homocystinuri
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.